Section 6 of 6
References
161 sources
- Adstiladrin prescribing information (2026) (opens in a new tab)
- American Cancer Society Cancer Facts and Figures (2026) (opens in a new tab)
- Anktiva prescribing information (2026) (opens in a new tab)
- Balar et al. (2021) (opens in a new tab)
- Beinfeld et al. (2021) (opens in a new tab)
- Bhanvadia et al. (2021) (opens in a new tab)
- Bivalacqua (2025) (opens in a new tab)
- Bivalacqua et al. (2026) (opens in a new tab)
- Boorjian et al. (2021) (opens in a new tab)
- Burke et al. (2010) (opens in a new tab)
- Burke et al. (2012) (opens in a new tab)
- CG Oncology BOND-003 24-month data press release (2025) (opens in a new tab)
- CG Oncology CORE-001 final results press release (2024) (opens in a new tab)
- CG Oncology CORE-001 Nature Medicine publication press release (2024) (opens in a new tab)
- CG Oncology CORE-001 protocol (2024) (opens in a new tab)
- CG Oncology expanded access program press release (2024) (opens in a new tab)
- CG Oncology Fast Track and Breakthrough Therapy press release (2023) (opens in a new tab)
- CG Oncology first-quarter 2026 results press release (2026) (opens in a new tab)
- CG Oncology Form 10-K (2026) (opens in a new tab)
- CG Oncology Form 10-Q (2026) (opens in a new tab)
- CG Oncology investor presentation (2026) (opens in a new tab)
- CG Oncology Lancet Oncology publication press release (2026) (opens in a new tab)
- CG Oncology PIVOT-006 topline press release (2026) (opens in a new tab)
- CG Oncology prospectus (2024) (opens in a new tab)
- CG Oncology SUO 2025 data press release (2025) (opens in a new tab)
- CG Oncology third-quarter 2025 results press release (2025) (opens in a new tab)
- CG Oncology third-quarter 2026 results press release (2026) (opens in a new tab)
- Chamie et al. (2013) (opens in a new tab)
- Chamie et al. (2024) (opens in a new tab)
- Chandra et al. (2023) (opens in a new tab)
- Chang et al. (2026a) (opens in a new tab)
- Chang et al. (2026b) (opens in a new tab)
- Chevuru et al. (2023) (opens in a new tab)
- Chun et al. (2023) (opens in a new tab)
- ClinicalTrials.gov NCT00109655 (opens in a new tab)
- ClinicalTrials.gov NCT01438112 (opens in a new tab)
- ClinicalTrials.gov NCT02365818 (opens in a new tab)
- ClinicalTrials.gov NCT04387461 (opens in a new tab)
- ClinicalTrials.gov NCT04452591 (opens in a new tab)
- ClinicalTrials.gov NCT04752722 (opens in a new tab)
- ClinicalTrials.gov NCT06211764 (opens in a new tab)
- ClinicalTrials.gov NCT06443944 (opens in a new tab)
- ClinicalTrials.gov NCT07283835 (opens in a new tab)
- Clinton et al. (2026a) (opens in a new tab)
- Clinton et al. (2026b) (opens in a new tab)
- CMS Medicare Part B Payment Limit File (2026) (opens in a new tab)
- CMS Physician Fee Schedule Relative Value File (2026) (opens in a new tab)
- Cohen (2026) (opens in a new tab)
- Colbert et al. (2025) (opens in a new tab)
- Cooper et al. (2023) (opens in a new tab)
- D'Andrea et al. (2025) (opens in a new tab)
- Daneshmand et al. (2025) (opens in a new tab)
- de Jong et al. (2023) (opens in a new tab)
- Dinney (2026c) (opens in a new tab)
- Dinney et al. (2026a) (opens in a new tab)
- Dinney et al. (2026b) (opens in a new tab)
- Donahue et al. (2025) (opens in a new tab)
- eCQI CMS646v6 Intravesical BCG for NMIBC (2026) (opens in a new tab)
- enGene LEGEND Cohort 1 and BLA plan press release (2026) (opens in a new tab)
- European Association of Urology NMIBC Guidelines (2026) (opens in a new tab)
- Faraj et al. (2020) (opens in a new tab)
- Farré et al. (2025) (opens in a new tab)
- FDA BCG-unresponsive NMIBC draft guidance (2024) (opens in a new tab)
- FDA BCG-unresponsive NMIBC guidance (2018) (opens in a new tab)
- FDA nogapendekin alfa inbakicept-pmln expanded indication notice (2026) (opens in a new tab)
- Ferring Adstiladrin Connecticut WAC disclosure (2026) (opens in a new tab)
- Giatsoglou et al. (2026) (opens in a new tab)
- Gore et al. (2026) (opens in a new tab)
- Griebsch et al. (2025) (opens in a new tab)
- Haas et al. (2016) (opens in a new tab)
- Heiss et al. (2025) (opens in a new tab)
- Herr et al. (2015) (opens in a new tab)
- ICER Bladder Cancer Final Evidence Report (2020) (opens in a new tab)
- ImmunityBio Anktiva Colorado WAC disclosure (2025) (opens in a new tab)
- ImmunityBio ISPOR 2026 health economic analysis press release (2026) (opens in a new tab)
- Inlexzo prescribing information (2025) (opens in a new tab)
- Jazayeri et al. (2026) (opens in a new tab)
- Joshi et al. (2023) (opens in a new tab)
- Jung et al. (2019) (opens in a new tab)
- Kamat et al. (2016) (opens in a new tab)
- Kamat et al. (2023) (opens in a new tab)
- Kassouf et al. (2026) (opens in a new tab)
- Kates et al. (2020) (opens in a new tab)
- Kissei Pharmaceutical Lancet Oncology publication press release (2026) (opens in a new tab)
- Kurnot and Kaye (2024) (opens in a new tab)
- Lenis et al. (2020) (opens in a new tab)
- Lerner et al. (2015) (opens in a new tab)
- Li et al. (2021) (opens in a new tab)
- Li et al. (2023) (opens in a new tab)
- Li et al. (2024a) (opens in a new tab)
- Li et al. (2024b) (opens in a new tab)
- Lindskrog et al. (2021) (opens in a new tab)
- Lotan et al. (2025) (opens in a new tab)
- Mariotto et al. (2020) (opens in a new tab)
- Marqueen et al. (2018) (opens in a new tab)
- Mauskopf et al. (2007) (opens in a new tab)
- Merck KEYTRUDA cost information (2026) (opens in a new tab)
- Merck KEYTRUDA prescribing information (2026) (opens in a new tab)
- Merck TICE BCG HCP letter (2026) (opens in a new tab)
- MHLW orphan regenerative medical product designation (2025) (opens in a new tab)
- Miyake et al. (2026) (opens in a new tab)
- Mohamed et al. (2021) (opens in a new tab)
- Mokkapati (2025) (opens in a new tab)
- Mossanen et al. (2019) (opens in a new tab)
- Moyer et al. (2026a) (opens in a new tab)
- Moyer et al. (2026b) (opens in a new tab)
- Myers et al. (2024) (opens in a new tab)
- Myers et al. (2026) (opens in a new tab)
- Nadelmann et al. (2026) (opens in a new tab)
- Narayan et al. (2024) (opens in a new tab)
- National Cancer Institute PDQ Bladder Cancer Treatment (2025) (opens in a new tab)
- Nature Medicine CORE-001 article Table 1 (2024) (opens in a new tab)
- Nature Medicine CORE-001 article Table 2 (2024) (opens in a new tab)
- Nature Medicine CORE-001 author correction (2024) (opens in a new tab)
- Nature Medicine CORE-001 publisher correction (2024) (opens in a new tab)
- Nayak et al. (2021) (opens in a new tab)
- Necchi et al. (2024) (opens in a new tab)
- Nemunaitis et al. (2008) (opens in a new tab)
- Packiam et al. (2018) (opens in a new tab)
- Pinton et al. (2026) (opens in a new tab)
- Presicce et al. (2021) (opens in a new tab)
- Preston (2026) (opens in a new tab)
- Raj et al. (2007) (opens in a new tab)
- Rieger et al. (2024) (opens in a new tab)
- Robesti et al. (2026) (opens in a new tab)
- Scilipoti et al. (2025) (opens in a new tab)
- SEER Cancer Stat Facts Bladder Cancer (2026) (opens in a new tab)
- Senzer et al. (2006) (opens in a new tab)
- Shabsigh et al. (2009) (opens in a new tab)
- Shimko et al. (2011) (opens in a new tab)
- Smith et al. (2026) (opens in a new tab)
- Steinberg et al. (2016) (opens in a new tab)
- Steinberg et al. (2020) (opens in a new tab)
- Steinberg et al. (2026) (opens in a new tab)
- Su et al. (2025) (opens in a new tab)
- Sullivan et al. (2014) (opens in a new tab)
- Svatek et al. (2014) (opens in a new tab)
- Sylvester et al. (2006) (opens in a new tab)
- Sylvester et al. (2021) (opens in a new tab)
- Tan et al. (2023) (opens in a new tab)
- Tan et al. (2026) (opens in a new tab)
- Taylor et al. (2025a) (opens in a new tab)
- Taylor et al. (2025b) (opens in a new tab)
- Tyson (2025a) (opens in a new tab)
- Tyson (2025b) (opens in a new tab)
- Tyson (2025e) (opens in a new tab)
- Tyson et al. (2025c) (opens in a new tab)
- Tyson et al. (2025d) (opens in a new tab)
- Tyson et al. (2026) (opens in a new tab)
- Uchio et al. (2020) (opens in a new tab)
- Uchio et al. (2021) (opens in a new tab)
- Valstar prescribing information (2016) (opens in a new tab)
- WHO proposed INN List 127 (2022) (opens in a new tab)
- WHO recommended INN List 89 (2023) (opens in a new tab)
- Williams et al. (2021) (opens in a new tab)
- Williams et al. (2025) (opens in a new tab)
- Williams et al. (2026) (opens in a new tab)
- Wymer et al. (2021) (opens in a new tab)
- Yang et al. (2021) (opens in a new tab)
- Yang et al. (2026) (opens in a new tab)
- Zhang and Qi (2024) (opens in a new tab)